Emergent BioSolutions (EBS) Non-Current Debt (2010 - 2026)
Emergent BioSolutions (EBS) posted Non-Current Debt of $589.7 million for Q2 2026, little changed on a QoQ basis from $589.7 million in Q1 2026, and down 15.76% year-over-year from $700.0 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Non-Current Debt (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Non-Current Debt for 17 years, with the latest figure at $589.7 million in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 15.76% year-over-year to $589.7 million in Q2 2026; TTM through Jun 2026 was $589.7 million, a 15.76% decrease from a year earlier, with the FY2025 full-year figure at $589.7 million, down 15.76% from the prior year.
- Non-Current Debt was $589.7 million for Q2 2026 at Emergent BioSolutions, roughly flat from $589.7 million in the prior quarter.
- The five-year high for Non-Current Debt was $1.4 billion in Q4 2022, with the low at $589.7 million in Q4 2025.
- Average Non-Current Debt over 5 years is $844.7 million, with a median of $836.9 million recorded in 2022.
- The largest YoY upside for Non-Current Debt was 67.09% in 2023 against a maximum downside of 38.58% in 2023.
- Over 5 years, Non-Current Debt stood at $1.4 billion in 2022, then sank by 38.58% to $868.4 million in 2023, then dropped by 19.39% to $700.0 million in 2024, then decreased by 15.76% to $589.7 million in 2025, then changed by 0.0% to $589.7 million in 2026.
- The last three Non-Current Debt figures came in at $589.7 million (Q2 2026), $589.7 million (Q1 2026), and $589.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 42.86 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 17.02 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 882.16 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 589.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 589.70 Mn |
| Mar 31, 2026 | 589.70 Mn |
| Dec 31, 2025 | 589.70 Mn |
| Sep 30, 2025 | 693.10 Mn |
| Jun 30, 2025 | 700.00 Mn |
| Mar 31, 2025 | 700.00 Mn |
| Dec 31, 2024 | 700.00 Mn |
| Sep 30, 2024 | 700.80 Mn |
| Jun 30, 2024 | 863.80 Mn |
| Mar 31, 2024 | 909.20 Mn |
| Dec 31, 2023 | 868.40 Mn |
| Sep 30, 2023 | 866.30 Mn |
| Jun 30, 2023 | 909.30 Mn |
| Mar 31, 2023 | 1.41 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 832.70 Mn |
| Mar 31, 2022 | 841.10 Mn |
| Dec 31, 2021 | 849.60 Mn |
| Sep 30, 2021 | 858.00 Mn |
API Access
Emergent BioSolutions Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();